| 2012 | | Adefovir-based combination therapy with entecavir or lamivudine for patients with entecavir-refractory chronic hepatitis B | 김순선, 이명희, 정재연, 조성원 |
| 2011 | | Changes in liver stiffness measurement during antiviral therapy in patients with chronic hepatitis B. | 김순선, 김영배, 김진홍, 이명희, 임선교, 정재연, 조성원 |
| 2012 | | Changes in serum histologic surrogate markers and procollagen III N-terminal peptide as independent predictors of HBeAg loss in patients with chronic hepatitis B during entecavir therapy | 김순선, 김진홍, 유병무, 이광재, 이기명, 이명희, 정재연, 조성원 |
| 2016 | | Clinical course of partial virological responders under prolonged entecavir monotherapy in patients with chronic hepatitis B | 김순선, 박주한, 정재연, 조성원, 조효정 |
| 2011 | | Comparison of multiplex restriction fragment mass polymorphism and sequencing analyses for detecting entecavir resistance in chronic hepatitis B. | 조성원 |
| 2011 | | Correlation of serum hepatitis B surface antigen level with response to entecavir in naïve patients with chronic hepatitis B. | 김순선, 이명희, 정재연, 조성원 |
| 2014 | | Effect of virological response to entecavir on the development of hepatocellular carcinoma in hepatitis B viral cirrhotic patients: comparison between compensated and decompensated cirrhosis. | 김순선, 안선주, 임선교, 정재연, 조성원, 황재철 |
| 2010 | | Low efficacy of entecavir therapy in adefovir-refractory hepatitis B patients with prior lamivudine resistance. | 고경현, 이명희, 정재연, 조성원 |
| 2013 | | Multidrug-resistant hepatitis B virus resulting from sequential monotherapy with lamivudine, adefovir, and entecavir: clonal evolution during lamivudine plus adefovir therapy. | 김순선, 정재연, 조성원 |
| 2020 | | Predictive score for hepatocellular carcinoma after hepatitis B e antigen loss in patients treated with entecavir or tenofovir | 김순선, 정재연 |
| 2022 | | Renal safety of tenofovir disoproxil fumarate and entecavir in liver transplant patients: a nationwide Korean registry study | 김봉완 |
